You have read all your free articles, to continue reading subscribe to read the rest of this content.
Nordic Life Science asked Göran Forsberg, CEO of Cantargia, about Cantargia's future plans and his reactions to the Nobel Prizes. Congratulations on the listing on the main market Nasdaq Stockholm. What does this mean for the company? “Thank you! This means that the company will receive more exAlready a subscriber…
Nordic Life Science asked Claus Andersson, General Manager at Sunstone Life Science Venture, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges Nordic life science companies facing when it comes to raising capital. Copenhagen-bAlready a subscriber Login You have read all your…
Sprung from the University of Linköping’s world-renowned Center for Medical Image Science and Visualization and the departments of Biomedical Engineering and Medicine and Health, AMRA has become an international digital health company. Intended to aid in disease prediction, AMRA’s body compoAlready a subscriber Login You have read all your free…
The board of directors of Xvivo Perfusion AB has resolved to issue 1,950,000 new shares in Xvivo through a private placement directed to a group of qualified Swedish and international investors. The subscription price for each new share was set to SEK 37.50 through a book-building procedure. TAlready a subscriber Login You have…
